Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manal Batrawi"'
Autor:
Samir Arnaout, Georges Nemer, Ossama K. Abou Hassan, Steven R. DePalma, Manal Batrawi, Fadi Bitar, James S. Ware, Antoine Abchee, Mariam Arabi, Jonathan G. Seidman, Athar Khalil, Akl C. Fahed, Christine E. Seidman, Barbara McDonough
Publikováno v:
Circulation. Cardiovascular Genetics
Supplemental Digital Content is available in the text.
Background: Cardiac troponin I (TNNI3) gene mutations account for 3% of hypertrophic cardiomyopathy and carriers have a heterogeneous phenotype, with increased risk of sudden cardiac death (
Background: Cardiac troponin I (TNNI3) gene mutations account for 3% of hypertrophic cardiomyopathy and carriers have a heterogeneous phenotype, with increased risk of sudden cardiac death (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9338ff1ab859680e0a92cfd91bbe141b
http://hdl.handle.net/10044/1/82743
http://hdl.handle.net/10044/1/82743
Autor:
Samir Arnaout, Mariam Arabi, Athar Khalil, Jonathan G. Seidman, Akl C. Fahed, Steven R. DePalma, Christine E. Seidman, Manal Batrawi, James S. Ware, Fadi Bitar, Georges Nemer, Antoine Abche, Barbara McDonough
Publikováno v:
Circulation Research. 125
Hypertrophic Cardiomyopathy (HCM) occurs in 1 of every 500 people and has a wide phenotypic variability. In the majority of cases, HCM is caused by known mutations in genes that code for sarcomere proteins. Although gene testing is widely available f
Autor:
Mariam Arabi, Fadi Bitar, Jonathan G. Seidman, Akl C. Fahed, Ossama K. Abou Hassan, Manal Batrawi, Georges Nemer, Steven R. DePalma, Christine E. Seidman, Marwan M. Refaat
Publikováno v:
Scientific Reports
NKX2-5 mutations are associated with different forms of congenital heart disease. Despite the knowledge gained from molecular and animal studies, genotype-phenotype correlations in humans are limited by the lack of large cohorts and the incomplete as
Autor:
Christine E. Seidman, Georges Nemer, Barbara McDonough, Mariam T. Arabi, Akl C. Fahed, Steven R. DePalma, Antoine B. Abchee, Fadi F. Bitar, Jonathan G. Seidman, Samir Arnaout, Manal Batrawi, James S. Ware
Publikováno v:
Journal of the American College of Cardiology. 65:A958
Although gene testing is widely available for Hypertrophic Cardiomyopathy (HCM), determining the clinical implications of a mutation is limited by an understanding of its phenotype. Inbred populations with founder mutations provide an opportunity to